Company Filing History:
Years Active: 2020-2024
Title: Takayuki Kanazawa: Innovator in Cancer Treatment
Introduction
Takayuki Kanazawa is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 2 patents, Kanazawa is recognized for his work in creating pharmaceutical compositions that target cancer cells.
Latest Patents
Kanazawa's latest patents include a method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells. This invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8. Another significant patent is a method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8. This also offers a pharmaceutical composition for cancer treatment that includes an antibody against CCR8.
Career Highlights
Throughout his career, Kanazawa has worked with prominent organizations such as Shionogi & Company Limited and Osaka University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Tetsuya Yoshida and Yujiro Kidani. Their collaboration has likely played a role in the development of his innovative patents.
Conclusion
Takayuki Kanazawa's work in cancer treatment exemplifies the impact of innovation in medicine. His patents reflect a commitment to improving therapeutic options for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.